POINT Biopharma Global Inc. (PNT) financial statements (2022 and earlier)

Company profile

Business Address 4850 WEST 78TH STREET
INDIANAPOLIS, IN 46268
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments238,8161,095
Cash and cash equivalents238,8161,095
Prepaid expense2,175106
Other current assets105 
Other undisclosed current assets2,750 
Total current assets:243,8471,201
Noncurrent Assets
Property, plant and equipment19,412 
Assets held-in-trust 135,706
Total noncurrent assets:19,412135,706
TOTAL ASSETS:263,259136,907
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,980118
Accounts payable1,7385
Accrued liabilities5,991113
Taxes payable251 
Total current liabilities:7,980118
Noncurrent Liabilities
Liabilities, other than long-term debt66 
Deferred income tax liabilities66 
Other undisclosed noncurrent liabilities 4,750
Total noncurrent liabilities:664,750
Total liabilities:8,0464,867
Temporary equity, carrying amount 127,040
Stockholders' equity
Stockholders' equity attributable to parent, including:255,2135,000
Common stock9 
Additional paid in capital314,4895,311
Accumulated deficit(59,285)(312)
Other undisclosed stockholders' equity attributable to parent 0
Total stockholders' equity:255,2135,000
TOTAL LIABILITIES AND EQUITY:263,259136,907

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(45,512) 
Operating loss:(45,512) 
Nonoperating expense
(Other Nonoperating expense)
(85) 
Loss from continuing operations before income taxes:(45,597) 
Income tax expense(306) 
Net loss available to common stockholders, diluted:(45,902) 

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(45,902) 
Comprehensive loss, net of tax, attributable to parent:(45,902) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: